Russia-Ukraine conflict: UN General Assembly likely to vote again this week on Ukraine

UNITED NATIONS— The United Nations General Assembly is expected to vote this week, diplomats said, to call out Russia’s invasion of Ukraine for creating a “dire” humanitarian situation, urge aid access and again demand Moscow stop fighting and withdraw its troops.

It will be the second time the 193-member General Assembly votes on the Ukraine crisis since Russia launched what it calls a “special military operation” on Feb 24 to destroy Ukraine’s military infrastructure.

Ukraine, the United States and allies are looking to improve on the 141 yes votes cast to adopt a March 2 General Assembly resolution that deplored Russia’s “aggression against Ukraine.” Russia, Belarus, Eritrea, North Korea and Syria voted no, while 35 states – including China – abstained.

However, diplomats said South Africa has proposed a rival draft text on Ukraine’s humanitarian situation. The draft makes no reference to Russia. It was not immediately clear whether South Africa planned to put it to a vote.

General Assembly resolutions are nonbinding, but they carry political weight. The March 2 vote illustrated Russia’s international isolation over its invasion of Ukraine. While Russia is a veto power in the 15-member UN Security Council, no one country can block a General Assembly resolution.

The draft resolution put forward by Ukraine and allies for a likely vote this week focuses on the humanitarian situation – demanding the protection of civilians, medical personnel, aid workers, journalists, hospitals and other civilian infrastructure.

Ukraine and Western allies have accused Moscow of attacking civilians indiscriminately. Moscow denies attacking civilians.

The Ukraine and allies draft resolution also demands an end to the siege of cities, in particular Mariupol.

Ukraine defied Moscow’s demand for its soldiers to lay down arms before dawn on Monday in besieged Mariupol where hundreds of thousands of civilians are cowering from Russian bombardments laying waste to their city.

The second General Assembly vote comes after France and Mexico drafted a similar Security Council resolution, but did not call a vote because they said Moscow would have blocked it. Russia then put forward its own draft council text, but pulled it from a planned vote last week.

Source: NAM NEWS NETWORK

Ukraine-Russia War: Africa Undercuts Ability to Mediate, Analysts Say

Political analysts say South African President Cyril Ramaphosa has undercut his own utility as a potential mediator of the war in Ukraine with a controversial suggestion that NATO’s own actions are to blame for Russia’s invasion of its western neighbor.

Ramaphosa has said he prefers negotiations over weapons or economic sanctions, in reference to sanctions piled on Russia by the United States and Western allies in the aftermath of the invasion, now in its fourth week.

“The war could have been avoided if NATO had heeded the warnings from amongst its own leaders and officials over the years that its eastward expansion would lead to greater, not less, instability in the region,” Ramaphosa told parliament last Thursday.

But he added that South Africa “cannot condone the use of force and violation of international law.”

The South African president said South Africa had been asked to mediate in the conflict, but he did not mention who requested the intervention.

University of Western Australia analyst Dr. Muhammad Dan Suleiman told VOA that Ramaphosa’s “outrageous” comment is “more like stoking the fire of conflict (and) projecting a paradigm of war rather than peace." He said the comment undercuts any possibility for Ramaphosa to mediate peace talks between Russia and Ukraine.

Longtime allies

Africa's most industrialized nation has long-standing relations with the Kremlin dating back to the 1960s. During South Africa’s apartheid regime, the Soviet Union backed anti-apartheid freedom fighters.

After majority control came to South Africa in 1994, politicians, including those of the ruling African National Congress, maintained ties with Moscow, which observers say makes it no surprise that South Africa has not condemned Russia’s invasion.

Suleiman said there is no historical reason that gratitude for Soviet support during the apartheid era should translate to a defense of Russia’s aggression against Ukraine.

''For whatever reason, (Ramaphosa) seems to be equating Russia to the Soviet Union. And that is not true, because Ukraine was part of the Soviet Union. And so, whatever help the Soviet Union gave to the ANC during apartheid also had the contribution of Ukraine,'' Suleiman said.

Prince Mashele, executive director at the Center for Politics and Research in Pretoria, said Ramaphosa’s position doesn’t reflect the current thinking of most South Africans.

''You can't have a foreign policy that is frozen in the past. Foreign policy has to be dynamic. If (Ramaphosa) had a flexible policy, he would appreciate that the Russia of today is not the Russia of yesteryear.''

Mashele told VOA, "Ramaphosa is trapped by his own political party, the ANC, and so, the position he articulates doesn't reflect his own personal preference. In the ANC, there are relics of the old world aligned with the Communist Party of South Africa and (are) still active,” Mashele said.

Mashele disagrees with some analysts’ assertions that Black South Africans in 2022 continue to look to Moscow for support.

''I am Black. I come from Black communities. The majority of Black South Africans are actually inspired by the West. Their culture, mannerisms, are an extension of the West, in terms of thinking.''

He added, ''Black South Africans don't even wish to visit Moscow. They wish to visit New York, or Dubai in the East, or Europe. And so, the position that is articulated by Ramaphosa on behalf of South Africans doesn't reflect the thinking of Black people. It only represents the thinking of a political clique in the ANC.”

Source: Voice of America

Comply with and enforce judgements of regional court-ECOWAS chairman

ACCRA— President Nana Addo Dankwa Akufo-Addo has urged members of the Economic Community of West African States to comply with, and enforce judgements of the bloc’s Community Court of Justice (CCJ) for stronger integration of the region.

He noted that despite the best efforts of the Court to deliver on its mandate, it was constrained by the poor rate of enforcement of its judgements that presently stood at 13 per cent.

“Unless member states comply with the judgements of the ECOWAS Community Court of Justice, it will be difficult to build public confidence in the court…I appeal to all member states to ensure that they comply with their treaty obligations by observing and obeying the judgements of the court,” he said.

The President made the appeal when he opened the 11th external session of the CCJ in Accra on Monday.

He called on all member states that were yet to appoint competent national authorities for the enforcement of judgements of the Community Court to “respectfully do so without further delay.”

The Court’s external session will run from March 21 to April 1 this year at the Court Complex in Accra. The session forms part of efforts to bring justice closer to the grassroots for the benefit of indigent citizens who could otherwise not afford the attendant cost of litigation in the seat of the court at Abuja, Nigeria.

The session, which is a key activity of the annual work programme of the Court, also provides the opportunity for citizens to observe the Court in session, sensitize the public and engage with its stakeholders. It provides the opportunity for judicial dialogue with national courts of host countries.

Some sixty cases, one pertaining to Ghana, would be adjudicated by the Court during the session.

President Akufo-Addo however suggested to the Court to align its practices and procedures to the generally recognised rules of other international Courts to obviate any potential conflict between the courts and national governments.

He submitted that the CCJ should insist that all applicants for the exercise of the Courts expanded jurisdiction satisfied the requirement of the exhaustion of domestic remedies prior to filling their cases with the Court.

That, he said, would allow for the systematic development of the authority of the Court.

President Akufo-Addo noted that the CCJ, as the guarantor of ECOWAS Community norms, had a strategic role to play in the integration process of the bloc.

Thus, the Court must be supported to provide the enabling legal environment for the integration of the region.

Source: NAM NEWS NETWORK

Taconic Biosciences Improves rasH2 Carcinogenicity Test System Access in Asia-Pacific Region

Four-way distribution partnership provides quality, consistent rasH2 supply to India and China, better serving global customers

RENSSELAER, N.Y., March 21, 2022 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, has appointed Nomura Siam International Co., Ltd. (NSI) and Nomura Jimusho. Inc. (NJI) as sales agents and distributors of the rasH2 Mouse Carcinogenicity Test System in India and China, respectively. These distribution arrangements greatly improve rasH2 access for the burgeoning pharmaceutical industry in the Asia-Pacific region.

The rasH2 transgenic mouse model is the only short-term (6-month) carcinogenicity test system that is both accepted by global regulatory authorities and readily available in commercial production. Invented by the Central Institute for Experimental Animals (CIEA), the rasH2 model is widely used as an alternative to the 2-year carcinogenicity bioassay, providing a faster, more accurate test system that better aligns with Russell & Burch’s 3R tenets. Taconic and CLEA Japan, Inc (CLEA) have provided validated and consistent rasH2 mice for use in North America, Europe, and Asia since 2006, though access in India and China has been limited. As drug discovery and development activity increases in India and China, access to a carcinogenicity assay that is accepted by the US Food and Drug Administration (FDA) and European Medicines Agency (EMA), as well as local authorities, is vital.

Under the new agreement, NSI serves as sales agent and distributor for India and NJI as sales agent and distributor for China. These distributors and sales agents greatly simplify the transaction process for users located in these countries. NSI and NJI will leverage CLEA and Taconic production colonies in Japan, Denmark, and the US to meet customer demand, facilitating investigator access. Taconic, CLEA, and CIEA closely monitor these colonies and perform regular functional studies using positive control compounds to assure performance critical for drug safety assessment. The arrangement also allows CLEA and Taconic to align production to meet global demand through improved visibility into rasH2 global use and needs.

“The rasH2 model has delivered on the promise of transgenic technology by demonstrating exceptional value in carcinogenicity assessment of new drugs, and the worldwide adoption of this system is a testament to its advantages in terms of speed, specificity, and total cost,” said Dr. Michael Seiler, vice president commercial products at Taconic.

“This historic collaboration ensures customers in every country have full access to the rasH2 carcinogenicity test system,” said Ryuta Nomura, CIEA chairman of the board and CEO. “This partnership will significantly increase the likelihood that all customers globally receive rasH2 as requested with minimal delay, enabling studies to be performed sooner and ultimately helping to get new life-saving medications on the market faster.”

To learn more about the rasH2 model, please call 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email info@taconic.com.

About Taconic Biosciences, Inc.

Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom-generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, microbiome, immuno-oncology mouse models, and integrated model design and breeding services, Taconic operates service laboratories and breeding facilities in the US and Europe, maintains distributor relationships in Asia, and has global shipping capabilities to provide animal models almost anywhere in the world.

About CIEA:

Central Institute for Experimental Animals is a private and independent non-profit institute, founded in 1952 with the aim of contributing to medical care and medical science based on animal experiments.

About CLEA:

CLEA Japan Inc. was founded in 1965 as a total system supplier of laboratory animals, their diet and equipment, to support bioscience research and development with a vision of health, welfare, and environment for humans.

CLEA operates four breeding facilities in Japan, a joint venture facility in Thailand, and Technical Service Center near Mt. Fuji in Japan.

About Nomura Siam International Co. Ltd. (NSI):

Nomura Siam International Co. Ltd., based in Bangkok, Thailand, was jointly established in 2012 by CLEA Japan, Inc. and Nomura Jimusho, Inc. to provide a one-stop service for the laboratory animal field. As a one-stop service supplier, NSI not only sells laboratory animals but also handles a wide range of related products, including equipment for rearing animals and experiments, feeds, and bedding, as well as provides consulting services for preclinical research and designing facilities for laboratory animals.

About Nomura Jimusho. Inc. (NJI):

Established in 1933 for petroleum-related businesses and diversified the activities to deal in products with unique and distinct characteristics in fields such as oil-refining catalysts, special materials, plastic containers, specialty chemicals, and life sciences. In the life sciences field, NJI/NSI have been supplying laboratory animals and various laboratory animal equipment for over a decade to overseas market, such as China, Korea, Thailand, Singapore, Indonesia, Malaysia, and recently India in the partnership with Taconic Biosciences, Inc.

Media Contact:

Aidan Bouchelle
Associate Director, Marketing Operations
518-949-7598
Aidan.Bouchelle@taconic.com

Taconic Biosciences améliore l’accès au système d’essai de carcinogénicité rasH2 dans la région Asie-Pacifique

Le partenariat de distribution quadripartite prévoit un approvisionnement constant et de qualité du test rasH2 en Inde et en Chine afin de mieux satisfaire la clientèle mondiale

RENSSELAER, N.Y., 21 mars 2022 (GLOBE NEWSWIRE) — Taconic Biosciences, l’un des leaders mondiaux des solutions de modèles animaux pour la mise au point de médicaments, a nommé les entreprises Nomura Siam International Co., Ltd. (NSI) et Nomura Jimusho, Inc. (NJI) en tant qu’agents commerciaux et distributeurs du système d’essai de carcinogénicité sur rongeur rasH2 respectivement en Inde et en Chine. Ce partenariat de distribution améliorera considérablement l’accès au test rasH2 au profit de l’industrie pharmaceutique dans la région Asie-Pacifique, actuellement en plein essor.

Le modèle de rongeur transgénique rasH2 est le seul système d’essai de carcinogénicité à court terme (6 mois) qui soit à la fois homologué par les autorités réglementaires mondiales et aisément disponible aux fins de production commerciale. Inventé à l’origine par le CIEA (Central Institute for Experimental Animals), le modèle rasH2 est largement employé comme alternative à l’étude de carcinogénicité sur 2 ans, grâce à un système de test plus rapide, plus précis et mieux aligné avec les tènements 3R de Russell & Burch. Taconic et CLEA Japan, Inc (CLEA) fournissent des souris rasH2 validées et cohérentes pour une utilisation en Amérique du Nord, en Europe et en Asie depuis 2006, alors que l’accès en Inde et en Chine avait toujours été limité. L’activité de découverte et de développement de médicaments progresse en Inde et en Chine, au point que l’accès à un essai de carcinogénicité validé à la fois par la FDA (Food and Drug Administration) américaine, l’Agence européenne des médicaments (EMA) et les autorités locales était devenu essentiel.

En vertu de ce nouvel accord, NSI agira en qualité d’agent commercial et distributeur pour l’Inde, tandis que NJI officiera avec les mêmes prérogatives pour la Chine. Ces distributeurs et agents de vente simplifieront considérablement la procédure de transaction pour les utilisateurs situés dans ces pays. NSI et NJI tireront parti des colonies de production de CLEA et Taconic au Japon, au Danemark et aux États-Unis afin de répondre à la demande des clients en facilitant l’accès aux enquêteurs. Taconic, CLEA et CIEA surveillent étroitement ces colonies et effectuent régulièrement des études fonctionnelles à l’aide de composés de contrôle positifs afin d’assurer des performances critiques pour l’évaluation de l’innocuité des médicaments. Cet arrangement contractuel vise également à permettre à CLEA et Taconic d’harmoniser leur production de manière à répondre à la demande mondiale grâce à une meilleure visibilité sur les usages et besoins mondiaux en matière de tests rasH2.

« Le modèle rasH2 a tenu les promesses de la technologie transgénique en démontrant sa valeur exceptionnelle lors de l’évaluation de la carcinogénicité des nouveaux médicaments. L’adoption mondiale de ce système témoigne de ses atouts en termes de rapidité, de spécificité et de coût total », a déclaré le Dr Michael Seiler, vice-président en charge des produits commerciaux chez Taconic.

« Cette collaboration historique garantit aux clients de tous les pays un accès complet au système d’essai de carcinogénicité rasH2 », a précisé Ryuta Nomura, président du conseil d’administration et PDG du CIEA. « Ce partenariat augmentera considérablement la probabilité que tous les clients du monde entier reçoivent le rasH2 conformément à la demande et avec un délai minimal, ce qui permettra aux études d’être réalisées plus tôt et, en fin de compte, contribuera à mettre plus rapidement sur le marché de nouveaux médicaments salvateurs », a ajouté M. Nomura.

Pour en savoir plus sur les produits et services de Taconic, veuillez composer le 1-888-TACONIC (888-822-6642) aux États-Unis, le +45 70 23 04 05 en Europe, ou envoyer un e-mail à l’adresse info@taconic.com.

À propos de Taconic Biosciences, Inc.

Taconic Biosciences est un leader mondial pleinement agréé dans les modèles et les services de rongeurs génétiquement modifiés. Fondée en 1952, Taconic offre les meilleures solutions animales afin que les clients puissent acquérir, générer d’une manière personnalisée, élever, pré-conditionner, tester et distribuer des modèles de recherche précieux dans le monde entier. Spécialiste des modèles de souris et de rats génétiquement modifiés, du microbiome, des modèles de souris pour l’immuno-oncologie et des services de conception de modèles intégrés et d’élevage, Taconic exploite des laboratoires et des établissements d’élevage aux États-Unis et en Europe, entretient des relations de distribution en Asie et dispose de capacités d’expédition mondiales pour fournir des modèles animaux presque partout dans le monde.

À propos du CIEA :

Le Central Institute for Experimental Animals est un institut privé indépendant non lucratif fondé en 1952 dans le but de contribuer aux soins médicaux et à la science médicale sur la base de l’expérimentation animale.

À propos de CLEA :

CLEA Japan Inc. a été fondé en 1965 en tant que fournisseur de systèmes complets d’animaux de laboratoire, comprenant leur alimentation et leur équipement, afin de soutenir la recherche et le développement bioscientifiques avec une vision sur la santé, le bien-être et l’environnement des êtres humains.

CLEA exploite quatre sites de reproduction au Japon, un site de production en coentreprise en Thaïlande, ainsi qu’un centre de services techniques à proximité du Mont Fuji au Japon.

À propos de Nomura Siam International Co. Ltd. (NSI) :

Nomura Siam International Co. Ltd., entreprise sis à Bangkok (Thaïlande), a été créée conjointement en 2012 par CLEA Japan, Inc. et Nomura Jimusho, Inc. afin de proposer un service à interlocuteur unique dans le domaine des animaux de laboratoire. En tant que prestataire de services unifiés, NSI commercialise non seulement des animaux de laboratoire, mais gère également une large gamme de produits connexes, y compris des équipements destinés à l’élevage et à l’expérimentation d’animaux, des aliments et des litières, en proposant par ailleurs des services de conseil en matière de recherche préclinique et de conception de sites pour animaux de laboratoire.

À propos de Nomura Jimusho. Inc. (NJI) :

Fondée en 1933 pour mener des activités liées au pétrole, l’entreprise s’est diversifiée au profit du négoce de produits présentant des caractéristiques uniques et distinctes dans des domaines tels que les catalyseurs de raffinage du pétrole, les matériaux spéciaux, les conteneurs plastiques, les produits chimiques spécialisés et les sciences de la vie. Dans le domaine des sciences de la vie, NJI/NSI fournit des animaux de laboratoire et divers équipements pour cobayes depuis plus d’une décennie sur le marché étranger, dont la Chine, la Corée, la Thaïlande, Singapour, l’Indonésie, la Malaisie et récemment l’Inde, en partenariat avec Taconic Biosciences, Inc.

Contact pour les médias :

Aidan Bouchelle
Directeur associé en charge des opérations marketing
518-949-7598
Aidan.Bouchelle@taconic.com